» Articles » PMID: 12592390

Inhibition of Ultraviolet B-mediated Activation of Nuclear Factor KappaB in Normal Human Epidermal Keratinocytes by Green Tea Constituent (-)-epigallocatechin-3-gallate

Overview
Journal Oncogene
Date 2003 Feb 20
PMID 12592390
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Epigallocatechin-3-gallate (EGCG), the major constituent of green tea, possesses significant anti-inflammatory and cancer chemopreventive properties. Studies have shown the photochemopreventive effects of green tea and EGCG in cell culture, animal models, and human skin. The molecular mechanism(s) of photochemopreventive effects of EGCG are incompletely understood. We recently showed that EGCG treatment of the normal human epidermal keratinocytes (NHEK) inhibits ultraviolet (UV)B-mediated activation of the mitogen-activated protein kinase (MAPK) pathway. In this study, we evaluated the effect of EGCG on UVB-mediated modulation of the nuclear factor kappa B (NF-kappaB) pathway, which is known to play a critical role in a variety of physiological functions and is involved in inflammation and development of cancer. Immunoblot analysis demonstrated that the treatment of NHEK with EGCG (10-40 microM) for 24 h resulted in a significant inhibition of UVB (40 mJ/cm(2))-mediated degradation and phosphorylation of IkappaBalpha and activation of IKKalpha, in a dose-dependent manner. UVB-mediated degradation and phosphorylation of IkappaBalpha and activation of IKKalpha was also observed in a time-dependent protocol (15 and 30 min, 1, 2, 3, 6, 12 h post-UVB exposure). Employing immunoblot analysis, enzyme-linked immunosorbent assay, and gel shift assay, we demonstrate that EGCG treatment of the cells resulted in a significant dose- and time-dependent inhibition of UVB-mediated activation and nuclear translocation of a NF-kappaB/p65. Our data suggest that EGCG protects against the adverse effects of UV radiation via modulations in NF-kappaB pathway, and provide a molecular basis for the photochemopreventive effect of EGCG.

Citing Articles

Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential.

Capasso L, De Masi L, Sirignano C, Maresca V, Basile A, Nebbioso A Molecules. 2025; 30(3).

PMID: 39942757 PMC: 11821029. DOI: 10.3390/molecules30030654.


Bioinformatics Analysis and Experimental Validation of Epigallocatechin-3-gallate Against Iopromide-induced Injury in HEK-293 Cells Anti-oxidative and Anti-inflammation Pathways.

Tsai Y, Tsai C, Yang J, Juan Y, Shih H, Bau D In Vivo. 2024; 38(6):2617-2628.

PMID: 39477405 PMC: 11535936. DOI: 10.21873/invivo.13738.


Phytocompounds-based therapeutic approach: Investigating curcumin and green tea extracts on MCF-7 breast cancer cell line.

Fawzy R, Abdel-Aziz A, Bassiouny K, Fayed A J Genet Eng Biotechnol. 2024; 22(1):100339.

PMID: 38494270 PMC: 10980874. DOI: 10.1016/j.jgeb.2023.100339.


Protective Mechanisms of Polyphenol-Enriched Blueberry Preparation in Preventing Inflammation in the Skin against UVB-Induced Damage in an Animal Model.

Alsadi N, Yasavoli-Sharahi H, Mueller R, Cuenin C, Chung F, Herceg Z Antioxidants (Basel). 2024; 13(1).

PMID: 38275645 PMC: 10812677. DOI: 10.3390/antiox13010025.


Innovative Rocuronium Bromide Topical Formulation for Targeted Skin Drug Delivery: Design, Comprehensive Characterization, In Vitro 2D/3D Human Cell Culture and Permeation.

Ruiz V, Encinas-Basurto D, Sun B, Eedara B, Roh E, Alarcon N Int J Mol Sci. 2023; 24(10).

PMID: 37240122 PMC: 10218466. DOI: 10.3390/ijms24108776.